期刊文献+

二甲双胍缓释片治疗女性精神分裂症伴发代谢综合征的研究 被引量:6

The Efficacy of Metformin SR Tablets in the Treatment of Female Schizophrenic with Metabolic Syndrome
下载PDF
导出
摘要 目的观察二甲双胍缓释片对女性精神分裂症患者所伴发代谢综合征(MS)的疗效。方法将64例符合MS诊断的女性精神分裂症患者随机分为研究组和对照组各32例。研究组给予二甲双胍缓释片500mg/d,对照组给予同等片型的安慰剂,各治疗3个月,分别于治疗前、治疗1个月和治疗3个月时检测体重指数(BMI)、腰围、收缩压、舒张压、空腹血糖(FBS)、甘油三酯(TG)和高密度脂蛋白(HDL-C),并进行比较分析。结果治疗1个月后研究组收缩压、舒张压、TG、HDL-C这4项指标均低于治疗组,差异具有显著性(分别t=2.36,2.25,2.37,2.03;P<0.05);研究组FBS水平明显低于对照组,差异具有极显著性(t=12.34,P<0.01。治疗3个月后,两组间BMI、腰围相比无显著差异(P>0.05);研究组收缩压和舒张压仍低于对照组,具有显著差异(t=2.63,2.60;P<0.05);研究组的FBS、TG和HDL-C水平明显低于对照组,有极显著差异(t=13.65,10.36,2.77;P<0.01)。结论二甲双胍缓释片对于女性精神分裂症伴代谢综合征患者有较好疗效。 Objective To study the effects of metformin SR tablets on female schizophrenic with metabolic syndrome(MS).Methods A total of 64 female patients diagnosed with MS were randomly divided into two groups-a research group and a control group.For three months,the research group were given metformin SR tablets 500 mg/day while the control group were given placebo of the same tablets.The patients' body mass index(BMI),waist circumference,systolic blood pressure and diastolic blood pressure,fasting blood sugar(FBS),triglycerides(TG)and high density lipoprotein(HDL-C)of each group were tested before the treatment,at the end of the first month and the third month of the treatment and were analyzed and compared.Results After a month of treatment,systolic blood pressure,diastolic blood pressure,TG and HDL-C of the control group were significantly lower than those of the research group(t=2.36,2.25,2.37,2.03;all P0.05);The FBS levels of the research group was significantly lower than that of the control group(t=12.34,P0.01).After three months of treatment,no significant difference(P0.05) was found between two groups in BMI and waist circumference;the systolic and diastolic blood pressures of the research group were still significantly lower than those of the control group(t=2.63,2.60;P0.05);the FBS and TG and HDL-C levels of the research group were significantly lower than those of the control group(t=13.65,10.36,2.77;all P0.01).Conclusion Metformin SR tablets has good curative effects on female patients with MS.
出处 《中国健康心理学杂志》 2012年第9期1290-1291,共2页 China Journal of Health Psychology
关键词 二甲双胍缓释片 女性 精神分裂症 代谢综合征 Metformin SR tablets Female Schizophrenia Metabolic syndrome
  • 相关文献

参考文献11

  • 1New comer J W. Metabolic syndrome and mental illness[J]. Am JM anag Care, 2007,13 Suppl(7) : 170-177. 被引量:1
  • 2Barnett A H,Mackin P,Chaudbry I,et aL Mininising metabolic and cardiovascular risk in schizophrenia diabetes obesity and dyslipi- deamia[J]. JP sychopharrn acol, 2007,21 (4) : 357-373. 被引量:1
  • 3Reaven G M. Banting lecture 1998. Role of insulin resistance in hu- man disease[J]. Diabetes, 1988,37 (12), 1595-1607. 被引量:1
  • 4Kay J P, Alemzadeh R, Langley G, et al. Beneficial effects of met- formin in normoglycemic morbidly obese adolescents [ J ]. Metabolism, 2001,50(12) :1457-1464. 被引量:1
  • 5Carlsen S M,Rossvoll O,Bjeve K S,et al. Metformin improves blood lipid pattern in nondiabetic patients with coronary heart disease[J]. J Intern Med, 1996,239 (3) : 227-235. 被引量:1
  • 6邓宏明,肖常青,夏宁,于志清,李世生.二甲双胍治疗2型糖尿病人对血压影响的研究[J].高血压杂志,2002,10(3):197-199. 被引量:44
  • 7沈文龙,李晨虎,饶顺曾,占归来,张红.精神分裂症患者伴发代谢综合征的患病率调查[J].神经疾病与精神卫生,2007,7(6):431-433. 被引量:41
  • 8徐叔云.临床药理学[M].2版.北京:人民卫生出版社,2002:337-339. 被引量:3
  • 9Despres J P. Potential contribution of metformin to the management of cardiovascular disease risk in patients with abdominal obesity, the metabolic syndrome and type 2 diabetes[J]. Diabetes Metab, 2003, 29(2) : 653-661. 被引量:1
  • 10张维君,康云鹏.女性代谢综合征及其相关心血管疾病的评估与控制[J].心血管病学进展,2008,29(4):507-510. 被引量:6

二级参考文献30

共引文献115

同被引文献84

  • 1吴仁容,赵靖平.四种抗精神病药对糖代谢及脂代谢的不良影响[J].中华精神科杂志,2005,38(3):130-133. 被引量:83
  • 2吴仁容,赵靖平,邵平,何益群,房茂胜,刘毅君,国效峰.二甲双胍联合行为干预治疗抗精神病药所致体质量增加及糖代谢紊乱的研究[J].中华精神科杂志,2007,40(4):193-196. 被引量:17
  • 3Mc Evoy J P, Meyer J M, Goff D C, et al. Prevalence of the metabolic syndrome inpatients with schizophrenia : Baseline results from the Clini- cal Antipsychotic Trials of Intervention Effectiveness ( CATIE ) schizo- phrenia trial and comparison with national estimates from NHANES Ⅲ [ J]. Schizophr Res ,2005,80( 1 ) : 19-32. 被引量:1
  • 4Musso G, Cambino R, Cassader M, et al. A meta - analysis of random- ized trials for the treatment of nonalcoholic fatty liver disease [ J ]. Hep- atology,2010,52 ( 1 ) :79-104. 被引量:1
  • 5Nair S, Diehl A M, Wiseman M, et al. Metformin in the treatment of non- alcoholic steatohepatitis: A pilot open label trial [ J ]. Aliment Pharmacol Ther,2004,20 ( 1 ) : 23-28. 被引量:1
  • 6Uygun A, Kadayifci A, Isik A T, et al. Metformin in the treatment of patients with non- alcoholic steatohepatitis[ J ]. Aliment Pharmacol T- her,2004,19 (5) :537-544. 被引量:1
  • 7Coeeurello R, Brina D, Caprioli A, et al. 30 days of continuous olazap- ine infusion determines energy imbalance, glucose intolerance, insulin resistance, and dyslipidemia in mice [ J ]. J Clin Psyehopharmaeol, 2009,29 (6) :576-583. 被引量:1
  • 8Hasnain M, Fredriekson S K, Vieweg W V R, et al. Metabolic syn- drome associated with sehizophrenia and atypieal antipsyehoties [ J]. Curt Diab Rep ,2010 ,10 :209-216. 被引量:1
  • 9Kyoung K J,Park J,Lee S Y,et al. Atypical antipsychotic drugs per- turb AMPK - dependent regulation of hepatic lipid metabolism [ J ]. Am J Physiol Endocrinol Metab ,2011,300(4 ) :624-632. 被引量:1
  • 10Baptista T, Rangel N, Femondez V, et al. Mefformin as an weight gain adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration : A muhicentric, double - blind, pla- cebo - controlled trial [ J ]. Schizophr Res,2007,93 ( 1/3 ) :99-108. 被引量:1

引证文献6

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部